In the first part of a two-part interview, Mann discusses the state of technology in proteomics and what still needs to get done for proteomics to cross to the clinical side.
Millipore is betting that the buy, which is expected to close in the next several weeks, will provide its customers a powerful cell biology/protein expression-analysis tool for the benchtop.
Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.
Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.
